Mama-Match
MEDVi review
⛔ Carries an FDA warning letter for a misbranded compounded product (#721455, February 2026). It names its pharmacies with addresses, but publishes only the first month's price.
- Ask about HSA/FSA
- Independently scored
- Confirm total cost
Our medical guides link to published research and official medication information. Provider reviews compare published costs and terms. These source checks do not replace clinical review or advice from your healthcare professional.
Other providers to compare with MEDVi
Providers to compare, with referral partners listed first. Placement and score are separate; some links earn MamaGLP a commission.
- Meet CoreAge Rx
Compounded semaglutide and tirzepatide with advertised flat prices; clarify the offer and renewal rules before paying.
- Meet yourEra
yourEra advertises semaglutide from $79 and tirzepatide from $159 with care and shipping included; confirm your refill amount and schedule.
- Meet Willow
Injections from $299 and $399/mo, with higher dose tiers; compounded tablets, named doctors and coverage in 36 states.
MEDVi at a glance
- Semaglutide
- From $179 the first month; no ongoing rate published
- Tirzepatide
- No compounded tirzepatide price on its public page
- Coverage
- No state list on the GLP-1 page
- Brand-name
- Yes
How we scored MEDVi
The Mama-Match Score of 49/100 for MEDVi combines six editorial assessments using the same weighted six-factor framework we apply to every provider. It is not a clinical quality rating. A recent source check does not mean every factor was rescored; read the published terms and the methodology alongside the number. Referral payments do not change the score.
Considers the intake steps, payment timing and information available before enrollment.
Considers the full treatment cost, introductory offers and billing commitments.
Considers the described clinical team, appointment access and ways to contact a prescriber.
Considers published state coverage and treatment-specific eligibility limits.
Considers follow-up appointments, refill reviews and access to ongoing clinical support.
Considers cancellation deadlines, refund limits and prepaid commitments.
How we verified this review
- Last reviewed
- August 2026
- Confidence
- High
- Primary sources
Company website and regulatory records
The first thing to say is what its site says nowhere: MEDVi, LLC carries an FDA warning letter dated February 20, 2026 for false or misleading claims and a misbranded compounded product. The entity matches the one in its own privacy policy, a Delaware corporation with an address in Newark. That said, it does something almost nobody here does: it names its partner pharmacies with address and phone, and it offers brand medication alongside the compounded product. The published prices — $179 for the injection, $249 for the tablet — are first-month figures; the ongoing rate never appears, and the brand options are sold as $99 membership plus the cost of the medication, on the same page that promises no memberships and no hidden fees. Its marketing copy, too, is line-for-line identical to RxSaludable's.
What to expect when you sign up
We walked MEDVi's public signup (August 2026) — a first-hand look at the process. We did not create accounts, enter medical information, or complete checkout, so this is what any visitor sees, not a patient's outcome.
- 1The GLP-1 page shows "Starting at $179" and "Starting at $249" before asking for anything
- 2The three brand options carry no price: they read "$99 Membership + Medication Cost"
What we noticed
- The published price is the first month's, not the ongoing rate
- Its Terms name the partner pharmacies with address and phone — something most of this list never does
Pricing
Prices re-verified
Compounded semaglutide
$179
Plan
Injection, first month
"Starting at $179" and "starts at $179 for your first month with no contract." The rate for the months after is not published.
Oral semaglutide
$249
Plan
Daily tablet, first month
"Starting at $249" for the dissolvable tablet.
Ask your account administrator whether the exact charges qualify for HSA/FSA reimbursement and what itemized receipts you need. Prices reflect what MEDVi disclosed publicly at our last review and change often; confirm the current number on MEDVi's site.
What we like
- Names its partner pharmacies with address and phone: Triad Rx in Daphne, Alabama, and RedRock Pharmacy in St. George, Utah
- Names the company in its privacy policy: MEDVi, LLC, a Delaware corporation, in Newark
- Offers FDA-approved brand medication — Wegovy in pill and injection, and Zepbound — alongside the compounded product
- Has an oral route: GLP-1 tablets as well as the injection
- Includes dietitian visits and ongoing support at no extra cost, per its own page
The caveats
- ⛔ FDA warning letter #721455, dated February 20, 2026, to MEDVi, LLC, for false or misleading claims and a misbranded compounded product
- ⛔ Publishes only "from $179" for the first month; the ongoing rate is nowhere on the page
- "No membership or hidden fees!" sits on the same page as three brand options costing "$99 membership + medication cost"
- Its own patient counts contradict each other: "500,000+ patients" in the header and "10,000+ patients" further down
- No state list on the GLP-1 page
- ⚠ Its marketing copy is identical, line for line, to RxSaludable's, testimonials included
MEDVi for moms: our verdict
⛔ Carries an FDA warning letter for a misbranded compounded product (#721455, February 2026). It names its pharmacies with addresses, but publishes only the first month's price. It runs about $179/mo.
We looked at MEDVi the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.
What MEDVi actually costs
- Compounded semaglutide — Injection, first month: $179/mo
- Oral semaglutide — Daily tablet, first month: $249/mo
That's roughly in line with our list's median of ~$179/mo.
That price covers the consult, the medication, shipping and coaching.
The medications MEDVi prescribes
MEDVi prescribes semaglutide (the active drug in Wegovy and Ozempic). It can point you toward FDA-approved brand-name medications as well as the compounded versions — approved products carry the manufacturer's own pregnancy and breastfeeding label, which is cleaner to hand to an OB-GYN.
If you prefer an option without needles, check the exact product offered. FDA-approved oral semaglutide tablets have their own clinical trials and prescribing labels. Compounded oral or sublingual products are different: they are not FDA-approved and cannot be assumed equivalent to an approved tablet or injection. Ask the clinician about the formulation, evidence and instructions.
Where it operates. MEDVi publishes no state list, so confirm it serves yours before you pay anything.
Where MEDVi fits — and where it doesn't — for moms
A good fit if…
- the monthly cost is a real barrier and you want a low, predictable number.
Look elsewhere if…
- a clean regulatory record is non-negotiable for you — look at the FDA warning letter flagged in the cons above.
- you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.
Trust, safety and oversight
Before choosing MEDVi, confirm the dispensing pharmacy and the clinician responsible for your prescription. Public information alone does not establish the quality of care you will receive. It has an FDA warning letter, flagged in the cons — read it before you start. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.
Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.
The bottom line
MEDVi is a provider we list only with the full story attached — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.
The bottom line
Best for: A reader comparing brand access and named pharmacies, who is going to weigh the FDA warning letter before anything else.
Keep comparing MEDVi
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
MEDVi, answered
- How much does MEDVi cost?
- As of our last review, MEDVi's published pricing starts around $179/mo (From $179 the first month; no ongoing rate published semaglutide, No compounded tirzepatide price on its public page tirzepatide). Confirm the current all-in price on MEDVi's site before you commit.
- Is MEDVi safe to use while breastfeeding?
- Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.
- Does MEDVi offer both semaglutide and tirzepatide?
- We have not confirmed that MEDVi offers both medications. Ask which medication, formulation and dose are currently available before enrolling.
- Where does MEDVi land in your ranking?
- MEDVi scores 49/100 on our Mama-Match Score (rank #228), which weights six things that matter to a first-timer. Compare the scorecards and our published methodology before choosing a program.
Prices, states and verification reflect what MEDVi disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is background information, not medical advice. Pregnancy and breastfeeding guidance depends on the drug and formulation. Read the current Wegovy label and Zepbound label. See our medical disclaimer and how we're funded.